• Point-of-Care Lipid Testing Market Poised To Register Healthy Expansion in Upcoming Years - The College of American Pathologists (CAP) defines point-of-care testing as testing performed at the site or near a patient with the result leading to a possible change in the care of the patient. Lipid level in the blood can be measured by point-of-care lipid testing, which is used to measure cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides. The amount of time consumed between diagnosis and treatment of a patient in hospitals, clinics, ambulances, and patient homes is significantly reduced with POC tests. Popularity of POCT is increasing due to timeliness, convenience, and potential to improve patient outcomes. These tests are generally based on two detection methods: antibody based and microbial particle based. A health care professional or a nurse performs the test, analysis is performed, and lastly the results are recorded. Tests include lateral flow immunochromatography, enzyme-linked immunosorbent assays (ELISA), and agglutination test. Read Report Overview: https://www.transparencymarketresearch.com/point-of-care-lipid-testing-market.html The health care industry has witnessed a major change in the past few years due to emerging technological innovations including biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing to a closer connection with the patient- point-of care technologies due to which it is becoming a part of the transformational healthcare landscape. Increase in geriatric population, rise in prevalence of cardiovascular and diabetic diseases, and increased health care awareness are the major drivers of the market. Other factors augmenting the market are recent technological advancements, user-friendliness, and accuracy. Unhealthy and sedentary lifestyle habits are anticipated to provide new entrants with a wider user group. Improved technology, lab automation to provide cheaper, accurate, and high quality results, and increased home care facilities with rapid and effective diagnostic results also contribute to the growth of the point-of care lipid testing market. Rapidly increasing cost of POC lipid testing and stringent and time-consuming ambiguous regulatory frameworks are expected to hamper market growth during the forecast period. Rural locations with limited lab services and shortage of trained laboratory workers present an opportunity for new entrants in developing countries. Based on product type, the POC lipid testing market has been segmented into consumables and instruments. In terms of application, the market has been segmented into hypertriglyceridemia, hyperlipoproteinemia, Tangier disease, hyperlipidemia, familial hypercholesterolemia, and others. Based on end-user, the POC lipid testing market has been segmented into hospitals, clinical diagnostic laboratories, and home care settings. POC lipid testing consumables are inexpensive, easy to handle, and primarily used by the geriatric population, triggering the growth of POC lipid testing in homecare setting due to which this segment is anticipated to grow significantly. The hospitals segment is projected to account for significant share of the POC lipid testing market due to availability of trained professionals and advanced medical infrastructure. Sedentary lifestyle and high fat diet contribute to the increasing incidence of hyperlipidemia followed by hypertriglyceridemia leading to cardiovascular diseases, thus for the management of critical cardiovascular conditions the use of PoC lipid testing device is rising in hospitals. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25535 In terms of region, the POC lipid testing market has been segmented into North America, EMEA, and Asia Pacific. According to European cardiovascular disease statistics (2017), CVD accounts for 45% of all the deaths in Europe and 35% of all deaths in the EU. Europe is anticipated to be the largest market for POC lipid testing due to high prevalence of CVD, development of hospital infrastructure, and favorable regulations. Asia Pacific is likely to be the next major market due to rapid development and increase in demand for diagnostic testing in countries such as China and India. The market is primarily dominated by established companies which has increase competition in terms of pricing, distribution partnership, and upgrade of products and technology. Key players in the POC lipid testing market include Alere, Inc., Abaxis, Inc., Polymer Technology Systems, Roche Diagnostics, Samsung Electronics Corporation, Bio-Rad Laboratories, The Menarini Group, and Nova Biomedical. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 22 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Dental Lasers Market Inclined to Deliver Positive Growth Results until 2025 - Dental lasers are devices that emit coherent light beams, which are suited to perform oral surgeries. These lasers eliminate the need of surgical instruments such as dental anesthetics, dental drills, and hand pieces. This offers benefits such as less trauma, less bleeding, and less contamination. These devices are being gradually accepted owing to their capabilities such as lower light exposure, short healing time, lack of requirement of anesthesia, and portability due to their small size. Based on the technology utilized, dental lasers can be classified into three types: diode lasers, carbon dioxide lasers, and yttrium aluminum garnet (YAG) lasers. Diode lasers are primarily used in soft tissue surgeries and cosmetic dental procedures such as bleaching. Diode laser has emerged to be a portable, affordable and user-friendly hand piece for soft tissue surgery. It offers various advantages such as accuracy in cutting gum tissues; bloodless surgery; and minimal swelling, scarring, and pain before and after the surgery. A carbon dioxide laser uses a mixture of gases such as carbon dioxide, nitrogen, helium, and hydrogen as medium to intensify power of the light. The laser can also absorb intracellular water of pathogens. Carbon dioxide laser is used in oral surgery due to its ability to give defined incision for surgery without much laceration of adjacent soft tissues and root canal disinfection. Read Report Overview: https://www.transparencymarketresearch.com/dental-lasers-market.html Increase in prevalence of dental disorders, rise in awareness about oral hygiene, and advancement in dental diseases diagnostics and treatment technologies are the major factors driving the Dental Lasers Market. Furthermore, increase in spending on cosmetic dentistry is boosting the demand for dental laser equipment. Cosmetic dentistry is witnessing significant growth rate in developed regions in the world such as North America and Europe due to the high disposable income of the population. Additionally, rise in geriatric population with high dental disorders is propelling the demand for dental lasers. Aging makes a person highly susceptible to gum diseases and tooth decay. However, high cost of dental lasers compared to that of their substitutes such as dental drills acts as the major factor hampering the dental lasers market. The dental lasers market can be segmented based on product type, application, end-user, and geography. In terms of product type, the Dental Lasers Market can be primarily categorized into diode lasers, carbon dioxide lasers, and yttrium aluminum garnet lasers. The diode lasers segment has been further sub-segmented into quantum well lasers, distributed feedback lasers, vertical cavity surface emitting lasers, heterostructure lasers, quantum cascade lasers, separate confinement heterostructure lasers, and vertical external cavity surface emitting lasers. Based on application, the Dental Lasers Market has been segmented into conservative dentistry, endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, tooth whitening, and others. In terms of end-users, the Dental Lasers Market can be segregated into dental clinics and hospitals. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22904 Geographically, the dental lasers market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global market for dental lasers due to the high awareness about dental procedures among people in the region and rapid increase in demand for these lasers in the U.S. North America accounts for large share of the global dental lasers market. It is followed by Europe. Increase in demand for dental lasers in developed countries in Europe such as the U.K., Germany, and France drives the growth of the market in Europe. The European public dental healthcare provision is well framed and set in place to ensure that people are encouraged to pay regular visits to the dentist. Increase in demand for dental lasers in countries such as India, China, and Japan in is expected to boost the dental lasers market in Asia Pacific. Rise in incidences of dental disorders and growth in awareness about diagnostic testing for various dental diseases are some of the key factors driving the dental lasers market in Asia Pacific. However, affordability and lack of availability of innovative dental laser products are hampering the dental lasers market in developing such as Middle East & Africa and Latin America. Despite this, the market in these regions is expected to witness sluggish growth, led by contribution from developing countries such as Brazil and South Africa. The outlook of the dental lasers market in countries in Latin America such as Mexico and Brazil is anticipated to be positive due to the evolving medical structure and increasing awareness for diagnostic testing. Major players operating in the market include AMD GROUP LLC, CAO Group Inc., Biolase, Inc., Danaher Corporation- Kavo Dental Gmbh (Danaher Corporation)-, Sirona Dental Systems Inc., and Zolar Technology & Mfg Co. Inc. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 22 2019 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Cancer Diagnostics Market Estimated to Reach US$ 76.8 Bn by 2026 end -

  Biotechnology companies are focusing on the development of genotype- and phenotype-specific drugs for chronic diseases such as cancer in order to ensure that next-generation drugs are more efficacious. Multiplex and multi-analyte biomarkers play an important role in the development of translational medicine, which facilitates the translation of basic research into medical advances. In line with this, most pharmaceutical and biotechnology companies are committing to associate their drugs with diagnostic assays, as a number of multiplex biomarkers are directly associated with particular drugs. The growing research and development activities in cancer diagnostics are thus expected to bring revolutionary technologies in cancer diagnostics and in turn would drive the growth of the cancer diagnostics market. Future Market Insights, in its latest report on cancer diagnostics, estimates that the global market for cancer diagnostics is expected to expand 2.3x in terms of revenue by 2026 over 2016 and is estimated to reach US$ 76.8 Bn by 2026 end.

  Cancer Diagnostics Market: Overview & Global Market Scenario

  Early detection of cancer requires suitable cancer diagnostics procedures to screen the asymptomatic population that is on average risk of cancer, particularly for breast cancer, cervical cancers, colon cancers and melanoma. Increasing awareness towards the early signs and symptoms of cancer among physicians and other healthcare professionals as well as the general population.

  The inclusion of cancer diagnostics and cancer screening tests to national cancer screening programs by various countries would flourish the global cancer diagnostics market. Regular mammography has been introduced in national cancer programs by major developed countries where the incidence of breast cancer is high. For instance, the U.S. government has included the National Mammography Program to its national cancer screening programs. The government of Australia conducts 3 cancer screening programs viz. BreastScreen Australia, National Cervical Screening Program and National Bowel Cancer Screening Program. Countries in Europe are increasingly adopting HPV DNA screening for cervical cancer as a part of National Cervical Cancer Programs.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-1090 

  Next generation sequencing (NGS) is the most cost-effective, time saving and successful technological advancement in cancer diagnostics in the last three decades. Revolutionary second-generation and third platforms for cancer diagnostics offered by Roche, Illumina and Life Technologies, Pacific Biosciences of California, Inc. are rapidly gaining adoption in the cancer diagnostics market. Many molecular pathology laboratories are transitioning from single molecular PCR protocols to NGS platforms and thus, the market for cancer diagnostics is expected to gain traction.

  However, despite the high value propositions of molecular diagnostics for cancer diagnosis, insufficient coverage for costly test procedures discourages majority of patients from pursuing these tests. Moreover, according to the new pricing policy for 2017, CMS has increased rates for several new CPT codes including next-gen sequencing and multi analyte algorithm assays. For instance, CMS increased the cost of next-generation sequencing tests for hereditary breast cancer-related disorders (CPT code 81432) from US$ 623 to US$ 925.

  It is anticipated that state Medicaid programs will also adjust their prices to reflect Medicare rates. Regulators of CMS as well as private payers are increasingly emphasizing on increasing value and single-source tests having strong evidence of clinical utility. In 2013, CMS discontinued the ‘code stacking’ method for molecular diagnostic reimbursement for cancer. The center has dissolved this policy due to the wrongful exploitation of payment scheme by some of the labs and has stopped paying bills for these tests until the new method of ‘market-based pricing’ comes into action by 2018.

  The biopsy segment is likely to dominate the global cancer diagnostics market, primarily due to the introduction of new and advanced techniques such as liquid biopsy and fine needle aspiration for lung cancer. However, the imaging cancer diagnostics segment is expected to gain significant traction due to the high efficiency of imaging technologies such as PET/CT.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-1090

  Cancer Diagnostics Market: Competitive Analysis

  The competition landscape in the global cancer diagnostics market is changing rapidly. Although molecular testing is a hotspot for investment in in vitro diagnostics, the market exhibits awfully delayed growth due to slow returns on investment. In spite of this, all big cancer diagnostics players in the global market are continuously investing in cancer diagnostics, including molecular biomarker testing, NGS, PET scanners, etc. Companies are also investing in the automation of existing molecular assays for cancer diagnostics to foster future growth prospects in the cancer diagnostics market; however, due to the strong competition among companies in the cancer diagnostics market, they may confront price erosion. For instance, Roche, in spite of being a global leader in cancer diagnostics for many years, has lost some ground after huge investments by its global peers such as Thermo Fisher Scientific Inc. and Merck KGaA, among others.

  (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Human Growth Hormone Market Positive Growth and Forecasts by 2023 - Market Research Future (MRFR’s) latest study reveals that the Global Human Growth Hormone Market will surge at an impressive CAGR of 7.50% during the review period (2018-2023). Growth hormone deficiency falls under the list of endocrine conditions. Growth hormone deficiency is prevalent across the globe and the reasons for the condition usually vary from person to person. Though the condition is rare, its prevalence rate has increased to a noteworthy level in recent times. In many cases, brain injury has been identified as a primary cause of growth hormones deficiency. Low level of growth hormone secretion can lead to altered body composition, osteoporosis, insulin resistance, lipid abnormalities, reduced energy levels, and reduced muscle strength. Low growth hormone secretion is usually an issue that starts at a young age and if not addressed promptly, may have major implications in later stages of life. Today, the level of awareness about the condition is much higher than in the past. Modern parents show higher vigilance in monitoring their offspring’s overall physical development and are quick to react to any anomaly they observe. Increasing awareness about endocrine disorders is reflecting favourably on the global human growth hormone market. Demand for growth hormones has increased substantially. Moreover, arrival of more effective hormones has had a positive impact on the popularity of such medical products. To Get Sample Report visit https://www.marketresearchfuture.com/sample_request/6494 Key Players for Global Human Growth Hormones Market Market Research Future (MRFR) recognizes the following companies as the key players in Human Growth Hormones Market: There are plenty of large and small market players which operate in this market all over the globe. Some of leading market players profiled in the report include Pfizer Inc., Novo Nordisk A/S, Anhui Anke Biotechnology Co. Ltd., Eli Lilly and Company, GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Novartis AG, Biopartners GmbH, Zhongshan Hygene Biopharm Co. Ltd., Merck KGaA, Ipsen S.A. and Lifetech Labs Segments for Global Human Growth Hormones Market MRFR’s report offers a thorough segmental analysis of the market on the basis of brand, route of administration, application, and distribution channel. By brand, the market has been segmented into norditropin, genotropin, mumatrope, sainzen, omnitrope and others. Among these, the norditropin segment is holds the dominant share of the market and is expected retain its positing over 2023. In 2017, the segment stood at USD 1494.98 Mn and is projected to witness a double-digit CAGR during the forecast period. By application, the market has been segmented into growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome, prader-willi syndrome and others. The growth hormone deficiency segment accounts for the largest share of the market and is expected to exhibit a CAGR of 7.07% during the assessment period. By route of administration, the market has been segmented into subcutaneous, intramuscular, intravenous and oral. The subcutaneous segment currently holds the leading position and accounted for more than two-third share of the market in 2017. The segment is expected to remain highly attractive throughout the assessment period. By distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies and e-commerce websites. The hospital pharmacies segment represented close to 40% market share in 2017 and is project to witness a health growth over the next couple of years. Regional Analysis for Global Human Growth Hormones Market The report covers the human growth hormone market across Americas, Asia Pacific (APAC), Europe, the Middle East & Africa. The market is Americas is expected to remain highly lucrative during the review period. In 2017, Americas commanded over 49.18% share of the market and is expected to maintain its dominant position in 2018 and beyond. Factors such as the increasing prevalence of growth hormone deficiency, high healthcare spending, and widespread awareness among consumers are partly driving the growth of the market in the region. Americas is followed by Europe and APAC respectively. Sales of human growth hormones have also picked up pace in GCC countries, which brings MEA under the radar of market players operating on a global level. To Browse Complete Report visit https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Next Generation Sequencing Market Forecasts by Industry Drivers, Regions Till 2023 - DNA technology has come a long way, and next generation sequencing is expected to take DNA technology further than ever before. Market Research Future's report on the global next-generation sequencing market divulges key details regarding the growth of the market as well as various vital facts, figures, and prediction of growth of the global market. Also known as massive parallel sequencing or high throughput sequencing technology, next-gen sequencing has been transformative for the field of genomic research as it allows the sequencing of a complete human genome in a very short amount of time. During the process, the genetic material is extracted, fragmented, and associated with various factors for amplification. As such, this technology is highly effective and advanced thus driving its adoption and growth. The improved speed and reduced costs are expected to drive market growth. Use in clinical applications, agricultural applications, and forensic applications are growing rapidly. Healthcare research and the high demand for food are key areas where next-generation sequencing is being used extensively. Increasing genetic disorders are being diagnosed which has drastically increased the demand for next-generation sequencing. Moreover, the use of this technology in drug discovery is significant and expected to drive growth as the demand for effective drug therapies increases. Increasing awareness, employment of various growth strategies and ongoing technical advancements are expected to provide the market with ample opportunity for growth. However, the high initial cost of implementing technologies, and the requirement for storage of large volumes of data as well as a lack of skilled workforce to run the technology are challenges to the growth of the market. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/6354 Key Players for Global Next Generation Sequencing Market Market Research Future (MRFR) recognizes the following companies as the key players in Next Generation Sequencing Market: There are plenty of large and small market players which operate in this market all over the globe. Oxford Nanopore Technologies, Ltd., BGI, Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo Fisher Scientific, Inc. are among the notable market players that have been included in MRFR’s competition tracking of the global next generation sequencing market. Segments for Global Next Generation Sequencing Market Analysis of the markets several parts are included in MRFR's segmental analysis which has been performed on the basis of technology, service & product, application, end-user, and region. The technology used in next-generation sequencing includes whole exome sequencing, CHIP sequencing, whole genome sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and RNA sequencing. By service & product, the next generation sequencing market has been segmented into consumables, sample preparation, platforms & services for platforms, and sequencing services. The sample preparation segment is further divided into end repair, A-tailing & size selection, quality control, library preparation & target enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned and expounded on in the report. Applications of next-generation sequencing include genetic screening, drug discovery, diagnostics, agriculture & animal research, and others. End-users of next-generation sequencing include hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end-users. Regional Analysis for Global Next Generation Sequencing Market The global next generation sequencing market is segmented into key regions which include the Americas, Asia Pacific, Europe, and the Middle East & Africa. North America in the Americas region is slated to lead the market with the largest share due to the high competition between market players in the region as well as the rising demand for next-gen sequencing in the healthcare sector of developed economies such as the US and Canada. Moreover, the presence of a significant healthcare sector in the region combined with growing investments in healthcare toward the development of therapies for chronic diseases will push growth during the forecast period. The European region has the second largest market due to the significant R&D activities that take place in the region with regards to various fields including healthcare. The presence of pioneering next-gen sequencing technology market players are expected to make an impact on the market. However, growth here is restrained due to regulations and fragmentation of the market across Europe. Browse Complete Report @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Operating Table Market Insights Report 2018 - Research and Markets - The global operating table market size was valued at US$ 864.3 million in 2017, and is expected to witness a CAGR of 4.3% over the forecast period (2018 – 2026). Operating table is one of the essential operation theatre equipment that plays an important role in achieving better treatment outcomes. This is owing to vital function support and customization it offers according to type and need of surgery. Ease-of-use, versatility, multi-functionality and optimized access to the operating area are some of the desired characteristics of operating table. Operating table has two major forms, first as manual /non-powered operating table and second as powered operating table that could be move up and down according to surgery needs. Tables and their individual segments are raised and lowered by mechanical gears or hydraulic piston systems using manual or electrical controls. Moreover, different designs of surgical table are available according to surgery needs such as ophthalmic surgery table, cardiology surgery table, and others. Increasing surgical needs worldwide to be major driving factor for growth of the operating table market. The high rate of unmet surgical needs is significant in developing economies such as China, India, Brazil, South Africa, ASEAN and other prominent countries. According study published in World Journal of Surgery in 2014, developed countries receives 73.6% world surgeries while the low income counties receives only about 3.5%. However, rapid development of quality healthcare infrastructure in these regions is expected to increase the healthcare spending thereby creating positive prospects for surgical equipment such as operating table. There is logical corollary innovation behind continuous growth of the operating table market, this is especially the case in developed regions such as North America and Europe that already have one of highest per capita expenditure and strong healthcare infrastructure. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2067 Market Dynamics Increase in number of surgical and minimally intervention surgical needs is a major factor for driving growth of the global operating table market. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS) 2016 statistics, the U.S. population invested over US$ 15 billion on combined surgical and non-surgical procedures, which registered an increase of US$ 1.5 billion, over the previous year (2015). The surgical procedures accounted for 56% of the total expenditures, while non-surgical procedures accounted for 44% of the expenditure, in 2016. Several manufacturers of operating table are focused on launching innovative operating table, considering needs of all stakeholders in healthcare. For instance, in 2017, Hill-Rom launched TruSystem 3000 mobile operating table, which is a cost-effective, reliable and ergonomic handling operating table suitable for various surgical disciplines. Moreover, it can be customized for different surgical procedures due to availability of head sections, leg sections, arm supports and anesthesia frames, which are easy to attach and dismantle through an intuitive, easy-to-use, coupling system. Furthermore, several companies are collaborating to introduce operating tables that target specific surgical needs. For instance, in November 2017, IMRIS and Hill-Rom’s— Trumpf Medical was approved by the U.S. Food and Drug Administration (FDA) as a new multi-functional operating room table, specifically designed for the IMRIS Surgical Theatre. This joint development integrates an IMRIS MR Neuro tabletop and Hill-Rom’s TruSystem 7500 Surgical Table platform with the IMRIS Surgical Theatre to support better patient treatment. Moreover, according to the analysis by Coherent Market Insights, increase in number of geriatric population worldwide is expected to propel growth of the operating table market. Geriatric population suffers various conditions that require surgical intervention (arthroscopy, knee replacement, eye surgeries, palliative care, kidney transplant, and others.), which would contribute for high number of surgeries in these population. According to the World Population Prospects Report published in 2017, the worldwide population is advancing toward higher age group. In 2017, an estimated 962 million people were aged 60 or over, which comprised 13% of the population worldwide. Moreover, the number is expected to reach 1.3 billion by 2025, registering a growth of around 3%, annually. Click To Reading More On Operating Table Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Global Biosimilars Market Positive Growth and Forecasts by 2023 - A Biosimilar is described as a biological, medical product which is an identical copy of the original medical product. Market Research Future (MRFR) has published and released a research report about the global biosimilars market that predicts massive enlargement for this market with 26% CAGR during the forecast period between 2016 and 2023. In terms of cash, the market has been anticipated to rise to the US $ 16.97 bn. Analyzing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. This report also covers insights on the major countries/regions in which this industry is flourishing, along with the list and description of untapped regions which could be the potential markets in the future. The key factors aiding the growth of the global biosimilars market include clinical trial activities for biosimilars, increasing demand for the cheap medical products, increasing incident of different diseases, and strategic collaborations resulting in enhanced productivity. However, lack of awareness and physician skepticism are the major restraining factor regarding market growth. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1329 Key Players for Global Biosimilars Market The key players in the global biosimilars market include Accord Healthcare (UK), Amgen Inc. (USA), Astra Zeneca (UK), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Eli Lilly (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis (Switzerland), Pfizer Inc. (USA), Samsung Bioepis (South Korea), Sandoz International GmbH (Germany), and Teva Pharmaceuticals Industries Ltd. (Israel). Latest Industry News Mundipharma, a network of independent pharma companies, has acquired Spanish biosimilars development company Cinfa Biotech. The deal gives Mundipharma, access to a biosimilar to Amgen’s Neulasta (pegfilgrastim). 10 OCT 2018 The new white paper issued by the Association of European Cancer Leagues, a nonprofit, pan-European organization of national and regional cancer societies, has called for the greater use of biosimilars as a means to increase patient access to cancer treatment, and reduce costs. 10 OCT 2018 Regional Analysis for Global Biosimilars Market The regional segmentation of the global biosimilars market segments the market into continent-based regional markets namely Asia Pacific, North America, Europe, and rest of the world (RoW). According to the report, Europe is the biggest regional market for the biosimilars due to the advanced medical research, increasing the prevalence of diseases and rising geriatric population. Due to technological advancement, Western Europe is a bigger market than Eastern Europe. The key country-specific markets in Western Europe include France, Italy, Spain, Germany, and the United Kingdom (UK), followed by the rest of Western Europe. North America is the second largest market, being ahead of Europe in terms of technological advancement and being equal to Europe in terms of medical research. North America‘s approach towards biosimilars is not as welcome as Europe‘s is. Major country-specific markets in North America are Canada and the United States of America (USA). The Asia Pacific has been expected to emerge as the fast-growing market during the forecast period. The country-specific markets generating maximum revenue in this region are Australia, India, Japan, South Korea, and China, followed by the rest of the Asia Pacific region. Segments for Global Biosimilars Market The segmentation global biosimilars market is on the basis of application, manufacturing, product, and region. The application based segmentation segments the market into blood-related disorders, immunity-related diseases, oncology, and other. Based on manufacturing, the market has contract manufacturing and in-house manufacturing. As per segmentation based on product, the market has been segmented into recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others. Recombinant glycosylated proteins have been further segmented into Monoclonal antibody (mAb) and EPO. Recombinant non-glycosylated proteins have been further segmented into growth hormones, insulin, and other. Browse Complete Report @ https://www.marketresearchfuture.com/reports/biosimilars-market-1329 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Orthokeratology Market : Consumption, Revenue, Applications and Growth Rate 2026 - The global orthokeratology market size was valued at US$ 37.6 million in 2017, and is expected to witness a CAGR of 7.0% over the forecast period (2018 – 2026). Orthokeratology (Ortho-k) is a process that uses specially designed contact lenses to temporarily reshape outline of the cornea to reduce myopia (nearsightedness). It is a non-surgical procedure, which offers advantage of reduced risk in comparison to refractive surgery. Ortho-k lenses are also termed as corneal reshaping contact lenses or overnight contact lenses to correct or control myopia. These lenses are prescribed to correct refractive errors primarily nearsightedness, astigmatism, and hyperopia. In some cases, ortho-k is also used to correct presbyopia and to slow the progression of childhood myopia. According to a study published by American Academy of Optometry 2015, use of orthokeratology lenses led to a consistent reduction in myopia progression of around 45% for a period of two-year and 30% over five years, in terms of axial length. Increasing prevalence of myopia and high myopia worldwide are expected to drive growth of the orthokeratology market The prevalence of myopia and high myopia is increasing worldwide at a significant rate. Myopia is a major public health concern and high myopia is ranked second, as the leading cause of visual impairment worldwide. According to the National Center for Biotechnology Information (NCBI) 2016 report, in East Asia, nearly 50% of urban population suffered from myopia and the prevalence among students was around 90%. Moreover, onset of visual complications from myopia occurs earlier than other causes of blindness such as cataract and thus its impact on quality of life is also observed earlier. According to the Eye Contact Lens journal 2018 study, the economic burden of eye diseases in the U.S. is around US$ 139 billion, with nearly US$ 16 billion spent on myopia correction alone. Therefore, methods for preventing myopia and controlling its progression have high demand across the globe. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2193 Moreover, prolong usage of laptops, smartphones, and tablets is causing digital eye strain leading to permanent eye damage among kids and young population. Young people whose nearsightedness is progressively increasing are the most suitable candidates for orthokeratology. All these factors are collectively increasing the demand for ortho-K eventually driving the orthokeratology market growth. Orthokeratology Market Restraints According to the NCBI 2016 report, factors such as onset of microbial keratitis, lack of training of practitioners and wearers, poor compliance to lens care regimens, improper fitting procedures, and lost to routine follow-ups can decrease the adoption of orthokeratology. Fitting orthokeratology lenses is a more time-consuming process and requires more expertise than fitting regular contact lenses. Ortho-K lens requires a series of office visits and potentially multiple sets of lenses. Therefore, it increases the overall treatment costs, which can be a significant factor limiting the orthokeratology market growth. Moreover, the cost of ortho-k, including follow-up care can vary significantly depending on the type and degree of refractive error and duration of myopia correction. In 2016, Ortho-k prices in the U.S. ranged from US$ 1,000 to US$ 2,000 (for both eyes). This cost can increase up to US$ 4,000 based on the difficulty of cases. Furthermore, orthokeratology is not covered completely by vision care insurance plans. Orthokeratology Market - Regional Insights On the basis of region, the global orthokeratology market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to generate a significant revenue share in global orthokeratology market in 2026, owing to increasing burden of short-sightedness among the regional population. According to a study published by Ulster University in 2015, rate of short-sightedness in the U.K. has doubled over the past 50 years, as children no longer spend enough time outdoors. Moreover, around 23% of teens suffer from myopia in the country. Click To Reading More On Orthokeratology Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Neuroscience conferences 2019 - Pulsus Group invites all the participants from all over the world to attend 9th Global Summit on Neuroscience and Neuroimmunology on May 22-23, 2019 in London, UK. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Scientific sessions of Neuroimmunology 2019 will be contrived on the theme “Unveiling the advances in the field of Neuroscience and Neuroimmunology”. Neuroimmunology 2019 is an elite stage to unite overall eminent researchers in the field of Neuroscience, Neuroimmunology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The aim of this conference is to stimulate new ideas in the various fields of neurology and neurological research. Other reasons are, gathering of world-class researchers and budding talent from across the globe, showcase your research and get world recognition, avail chances to interact with world-renowned scientists, perfectly designed schedule: Workshop, Expo areas, Brain sessions and many more, platform to network with fellow primary care clinicians, educational workshops on diagnosis and treatment of Neurological diseases. (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Respiratory Devices Market Segments, Demand, Growth, Future Insights & Forecast - 2027 -

  In an era of smart technologies, conventional devices are being transformed into more intuitive devices. The respiratory devices market is expected to witness transitions from conventional to smart respiratory devices. The challenges associated with empowering the patient population to manage respiratory disorders such as asthma and COPD is likely to spur the need for more simplified and patient-friendly respiratory devices. According to a latest research by Future Market Insights (FMI), the global respiratory devices market is expected to account for over US$ 34,178.1 Mn in terms of value by the end of 2027. The report on respiratory devices further projects significant growth potential with average year-on-year growth rate pegged at 9.2% through 2027.

  Respiratory Devices Market Overview & Global Scenario

  According to WHO, around 235 million people suffer from asthma each year globally. This high prevalence of respiratory disorders has also significantly impacted the death ratio owing to the lack of effectiveness of inhalers. In several cases, patients do not use respiratory devices/inhalers properly, which leads to uncontrolled asthma. The improper usage of respiratory devices/inhalers also leads to limited drug infusion to the lungs, which leads to poor disease control and increase in the cost of care. In May 2014, National Review of Asthma Deaths published that 2/3rds of mortalities in the UK could be managed with proper routine check-ups. The growing number of hospital admissions due to the improper usage of respiratory devices/inhalers has accelerated the development of first-generation smart respiratory devices/inhalers. These first-generation smart inhalers are built on Bluetooth-enabled technology, which is used to monitor respiratory devices/inhaler usage, patient data collection and dose reminders. However, these respiratory devices have significant room for further improvement as patients are looking for more integrated solutions that can reduce the size of inhalers.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-794 

  Respiratory Devices Market: Factors Impacting Growth in Revenue

  The growing demand for lightweight and easy to carry portable oxygen concentrators has created the need for innovations in the respiratory devices market. Easy availability of land and other important resources required for production of the respiratory devices with low cost labor the major key players operating in respiratory devices are planning to shift their production facilities to such places, which in turn is expected to change in profit margins of respiratory devices for the company The manufacturers of respiratory devices are investing in product development to drive innovation, which has resulted in the creation of lighter-weight and cost-effective portable oxygen concentrators. Manufacturers of respiratory devices are considering all aspects during the production designing of respiratory devices, which include aesthetics, packaging, noise level, battery life, etc. The company predicts that the portable oxygen concentrators segment in the respiratory devices market will reach US$ 2,061.5 Mn by the end of 2027 with a CAGR of 9.4% over the forecast period.

  Increasing preference for in-home respiratory therapy for patients suffering from chronic respiratory disorders or patients being treated for infection, which does not require hospitalization, is likely to boost the demand for home oxygen concentrators in respiratory devices market. This is likely to fuel the global demand for home oxygen concentrators in respiratory devices market. FMI predicts that the home oxygen concentrators segment in the respiratory devices market will grow with a CAGR of 6.9% over the forecast period. In-home ventilation therapy (CPAP & BiPAP) is also gaining popularity among COPD and Obstructive Sleep Apnea (OSA) patients. These types of in-home ventilation therapies have reduced the rate of hospitalisation and the overall cost of treatment.

  Request to View TOC @  https://www.futuremarketinsights.com/askus/rep-gb-794

  About the Respiratory Devices Market Report

  FMI has segmented the global respiratory devices market into product type, end user and region. In terms of revenue, the positive airway pressure devices segment in the respiratory devices market is expected to hold a significant revenue share over the forecast period. On the other hand, the respiratory devices consumables segment in the respiratory devices market will exhibit faster growth in terms of revenue through 2027.

  FMI’s report tracks some of the key companies in the respiratory devices market, which include Drägerwerk AG & Co. KGaA, Hamilton Medical AG, Massimo Corporation, General Electric Healthcare Limited, Inogen Inc., Teleflex Incorporated, ResMed. Inc., Smiths Medical, Medtronic PLC, Koninklijke Philips N.V., and Fisher & Paykel Healthcare Limited.

  (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• 3rd World Congress on Pharmacology and Clinical Trials - This World Pharmacology Congress 2019 is an exclusive event consisting of renowned keynote addresses, Plenary presentations and Panel discussions & Networking designed specifically for attendees from academic and government institutions along with highly esteemed members of leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. The 3rd World Congress on Pharmacology and Clinical Trials was designed with 40 presentations, case studies and panel discussions focused on the theme: Encompass key issues in research/clinical studies related to the field of Pharmacology (Added: Tue Jan 22 2019 Hits: 10 Rating: 0.00 Votes: 0) Rate It

• Porcelain Veneers Now Available at Smile Pad Dental Centres - Many people don’t like their teeth because they have chipped, stained or misshapen teeth that stand out when they smile. It is common for these people to have low self-esteem and fear being judged in social situations. Now, there is a new instant solution to improve the appearance of teeth - and the results can last up to fifteen years. Porcelain veneers change the colour, shape and position of teeth without invasive surgery. By working with ‘what you have’, Smile Pad can fix chipped, stained or misshapen teeth with a long-term solution. Porcelain veneers have been the number one treatment for improving the outward appearance of teeth with celebrities for a number of years. The manufacturing process is time-intensive and state-of-the-art. The costs involved have kept the treatment away from most patients, but it is now available to anyone who wants it. A veneer is a shell that fits over the front of the tooth. Porcelain is the best material for natural-looking veneers because it is a clean, solid white. It is also exceptionally durable and resistant to acids and alkalis - everything your mouth will experience. By applying a new surface to a tooth, you change the outward appearance of it for good. With careful design, it is possible to reshape teeth and give the patient a new smile. The veneer is affixed to a tooth using a bonding agent. To ensure good adhesion and a seamless, natural fit, it is sometimes necessary to remove some enamel. Only a small amount is removed, just enough so the veneer builds it back up. This way, the tooth stays the same thickness as it was before treatment. Because the preparation is slight, it is usually possible to have the complete treatment in one sitting. Once a veneer is bonded to a tooth, it will stay put for up to fifteen years. Some patients keep their veneers for even longer. Because porcelain does not stain, veneers offer a more permanent solution to white teeth than whitening gels. Smile Pad has a great deal of experience creating the perfect smile. We recommend porcelain veneers as one of our core cosmetic dentistry procedures. Unlike caps and crowns, veneers cover only the front surface of a tooth so are usually only for aesthetics, but they can also sometimes be necessary to improve the health of your mouth. The main applications for dental veneers are to close gaps, realign teeth, cover chips, cover yellowing of the teeth and prevent the progression of enamel erosion. About the Company: Smile Pad provides General Dentistry, Restorative Dentistry, Cosmetic Dentistry, Preventive Dentistry, Dental Implants and Orthodontic services. Website: https://www.smilepad.co.uk/ Company's Address : 3rd Floor, 210 South Street City : Romford County : Essex Country : UK Post code : RM1 1TG Landline number : 01932 879 838 Email ID : Ottershawdental@smilepad.co.uk (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• CBT : Cognitive Behavioral Therapy in Texas - Our environment is filled with many options and opportunities, but at times this can be overwhelming. Recognizing a need to be met is only the first step in making a change. Next, you must be able to sift through all the available ways to meet that need, and this is often the most challenging task. When it comes to receiving treatment for mental health symptoms, the number and type of providers and treatments can be equally overwhelming.

  When researching a provider that would be the best fit for you, it is important to look at the education and training of the provider, and the types of treatments they use. There are various treatment options which are short-term, leading to lasting changes in mood and behavior in only a few weeks or months. One such treatment is cognitive-behavioral therapy (CBT). CBT is based on research which has found what you think (cognitions) impacts how you feel and how you behave. When engaged in CBT, you work on identifying unhelpful thoughts that are leading to negative mood and behaviors. CBT is different from some of the original therapies because it is short-term and focuses on your present situation. While discussing the past might be helpful during some parts of the treatment, the focus of the treatment is usually on the thoughts and moods that are causing you difficulties currently.

  When looking for options for cognitive behavioral therapy in Texas, a convenient option is telepsychology. Dr. Mayfield, owner of Mindset Therapy, PLLC, states that telepsychology is an internet-based therapy service that allows you to conduct your appointment from the location most convenient for you. Telepsychology removes the travel time needed to get to/from an appointment, which makes scheduling treatment even more convenient. Providers at Mindset Therapy are trained in a variety of treatments for most mental health conditions, to include CBT. When ready to make a change and cognitive behavioral therapy in Texas is the best fit for you, contact the company that provides virtual house calls by your therapist.

  New patient appointments can be booked directly through https://www.mindsettherapyonline.com/contact.php

  About Mindset Therapy, PLLC

  Mindset Therapy, PLLC is the future of mental health treatment; leading the telepsychology revolution with execution of mental health services via video teleconferencing and providing technology driven mental health treatment that reaches the patient at the time and location of their choice. Mindset Therapy provides mental health treatment by a licensed online psychologist in Texas. Mindset Therapy is headquartered in Houston, TX and owned by Dr. Emily Mayfield. Dr. Mayfield is a licensed psychologist, a veteran of the United States Air Force, and a Cherokee Nation citizen.

  Contact Us Today, Mindset Therapy PLLC USA Call us: +1 (346) 800-7055 Email: mindsettherapyonline@outlook.com Web: https://www.mindsettherapyonline.com/ (Added: Tue Jan 22 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• CBT - Cognitive Behavioral Therapy in Texas - Our environment is filled with many options and opportunities, but at times this can be overwhelming. Recognizing a need to be met is only the first step in making a change. Next, you must be able to sift through all the available ways to meet that need, and this is often the most challenging task. When it comes to receiving treatment for mental health symptoms, the number and type of providers and treatments can be equally overwhelming.

  When researching a provider that would be the best fit for you, it is important to look at the education and training of the provider, and the types of treatments they use. There are various treatment options which are short-term, leading to lasting changes in mood and behavior in only a few weeks or months. One such treatment is cognitive-behavioral therapy (CBT). CBT is based on research which has found what you think (cognitions) impacts how you feel and how you behave. When engaged in CBT, you work on identifying unhelpful thoughts that are leading to negative mood and behaviors. CBT is different from some of the original therapies because it is short-term and focuses on your present situation. While discussing the past might be helpful during some parts of the treatment, the focus of the treatment is usually on the thoughts and moods that are causing you difficulties currently.

  When looking for options for cognitive behavioral therapy in Texas, a convenient option is telepsychology. Dr. Mayfield, owner of Mindset Therapy, PLLC, states that telepsychology is an internet-based therapy service that allows you to conduct your appointment from the location most convenient for you. Telepsychology removes the travel time needed to get to/from an appointment, which makes scheduling treatment even more convenient. Providers at Mindset Therapy are trained in a variety of treatments for most mental health conditions, to include CBT. When ready to make a change and cognitive behavioral therapy in Texas is the best fit for you, contact the company that provides virtual house calls by your therapist.

  New patient appointments can be booked directly through https://www.mindsettherapyonline.com/contact.php

  About Mindset Therapy, PLLC

  Mindset Therapy, PLLC is the future of mental health treatment; leading the telepsychology revolution with execution of mental health services via video teleconferencing and providing technology driven mental health treatment that reaches the patient at the time and location of their choice. Mindset Therapy provides mental health treatment by a licensed online psychologist in Texas. Mindset Therapy is headquartered in Houston, TX and owned by Dr. Emily Mayfield. Dr. Mayfield is a licensed psychologist, a veteran of the United States Air Force, and a Cherokee Nation citizen.

  Contact Us Today, Mindset Therapy PLLC USA Call us: +1 (346) 800-7055 Email: mindsettherapyonline@outlook.com Web: https://www.mindsettherapyonline.com/ (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Advanced Setups by Global Air Ambulance Service in Jabalpur - January 22, 2019 - Global Air Ambulance, a Company which is standing only to help and provide benefits to the needy, serious, and critical patients. Global Air Ambulance Service in prefers to distinguish authenticated medical services through our Private Charter and Commercial Airlines. It works with qualified MD Doctors and expert Paramedical Technicians to secure patients life. Global Air Ambulance is one of very highly established and hi-tech road ambulance service which has all types of medical assistance for the patients to transfer them from one city to another city. Global is the best solution for you as we have specialized doctors and medical team with advanced medical setups. It transfers patient under the supervision of MD doctors and healthcare experts and keeps all the medical equipment ready to give immediate service to serious patients. It is easy, safe, and quick service providers and is the first preference given company by the city people because it provides easy and safe transfer of the patients. Global Air Ambulance Service in Jabalpur provides complete advanced medical facility with full hi-tech healthcare equipment in our both charter and commercial air ambulance in Jabalpur with all healthcare experts. Global Air Ambulance in Jabalpur top ranking air ambulance service provider all over the city as it has many technical health machines and well-qualified doctors. Global Air Ambulance Jabalpur provides all the ICU emergency requirements for the sake of the needy in which advanced medical team and the entire sets of types of equipment such as- hi-tech ventilator, cardiac monitor etc. Global Air Ambulance Service from Jamshedpur provides all the ICU emergency services which are very helpful and accomplice for the serious patients from the initial city to destination under the full and advanced supervision. More@ https://www.globalairambulance.in/air-ambulance-services-in-jamshedpur/ (Added: Tue Jan 22 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Book the Global Air Ambulance Services from Delhi, Allahabad with the Emergency ICU Setup - Tuesday, January 22, 2019: - As we “Global Air Ambulance Services” are hereby to announce about the service charges which are charged to the customers for the facility of the Air Ambulance Services in any emergency cases are now deducted at its lowest in the comparison to other Air Ambulance Service provider available in India. Global Air Ambulance Cost is at its lowest with all the similar and upgraded facility of the Emergency Air Evacuation Support to the Patients with the preferred and required the support of the expertise Medical Faculty of the Specialist MD Doctors and other medical evacuation staff. Global Air Ambulance Services from Delhi is serving the citizens with the modern facility of the emergency air evacuation with the preferred support of transportation like Charted Aircraft, Commercial Stretcher, Train Ambulance, or Ground Ambulance to make the evacuation in the comfortable way with the Experts in handling Medical Emergency of the patients which are having chances to occur to the patients along the evacuation process. Global Air ambulance Service in Delhi is availing the support of the Air Ambulance facility to the needed one at the lowest service charges with the best setup of the medical emergency equipment. Global Air Ambulance in Delhi is availing the support of the Air Ambulance from Delhi to CMC Vellore, Delhi to Kolkata, Delhi to Bangalore, and several places as referred or preferred by the patient’s relatives. Global Air Ambulance Services from Allahabad is similarly providing the support of the Emergency Air Evacuation facility to the patients with the modern setup of the Emergency Medical Equipment and the required Medical faculties according to the patients case summary to avail the required treatments along the evacuation/medical tourism, to the destination to reach safely with the comfortable support. Global Air Ambulance in Allahabad is available with the Techni9cal Staff to support the queries related to the emergency facility of the Air Ambulance on +91-7042995886, +91-9773678523 with 24x7 availability and Support. More @ https://www.globalairambulance.in/air-ambulance-services-in-allahabad/ (Added: Tue Jan 22 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Bladder Evacuators Market Explores New Growth Opportunities by Leading Manufacturers - Bladder evacuator is a device used to perform catheter irrigation, tissue collection, and/or straining functions during transurethral prostate or bladder surgery. Bladder evacuator is made of semi-transparent polyphenols and polyvinyl chloride materials. The evacuator is sold in a sterile, peel-open package and is intended for one-time use only. Companies or manufacturers have introduced reusable bladder evacuators made of glass that can be used during transurethral prostate and bladder surgery. Its unique design and easy handling features ensure better functional ability. These factors are expected to increase demand for these device in laboratories in the near future. However, currently, bladder evacuator devices with syringe are designed to process the pain free surgical procedures, which may be used as an alternative to urinary or bladder surgical procedures. Read Report Overview: https://www.transparencymarketresearch.com/bladder-evacuators-market.html Rise in prevalence of bladder cancer and urinary infection, surge in geriatric population leading to high infection rate of urinary tract, growing applications of the bladder evacuator technique in various urinary or prostrate surgeries are major factors expected to drive the bladder evacuators market during the forecast period. Favorable reimbursements and technologically advanced designs introduced by manufacturers such as evacuator attached with syringe are likely to boost the growth of the bladder evacuators market during forecast period. However, rise in surgical cost and side effects of urinary bladder surgery are likely to restrain the market during the forecast period. Bladder evacuators are made up of three different types of material used for different urologic surgeries. Polyvinyl chloride and polypropylene bladder evacuators are currently the most widely adopted devices. However, promising results of bladder evacuators in various urologic surgeries and rise in clinical studies on prostate cancer is increasing the adoption of glass bladder evacuators and are expected to drive the products material type segment in the next future. Applications of bladder evacuators include urinary bladder surgery and prostrate surgery. Urinary bladder surgery uses bladder evacuators for evacuating irrigation solutions, blood clots, tissue collection, and straining functions. Various clinical trials are under way for the application of bladder evacuator technique in the treatment of other major surgical procedures. In terms of region, the global bladder evacuators market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market from 2017 to 2025, owing to increase in geriatric patient population suffering from urinary disorders, growing number of devices receiving regulatory approvals, rise in demand for new and advanced bladder evacuators, and favorable reimbursement policies for surgery. Moreover, increase in incidence of bladder cancer is likely to augment the market in North America during the forecast period. According to the American Cancer Society, in 2017, about 79,030 new cases of bladder cancer are projected to be reported in the U.S. alone. Bladder cancer accounts for nearly 5% of all new cancers in the U.S. This along with increase in approvals for different surgical procedures for bladders by surgeons develops wide opportunities for the market players to operate the bladder evacuators in the North America region. However, rise in incidence of prostate cancer surgeries in Asia Pacific and increase in health care expenditure are expected to drive the bladder evacuators market in Asia Pacific from 2017 to 2025. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34058 Key players operating in the global bladder evacuators market include MEDpro Medical, Medi-Tech Devices, Boston Scientific Corporation, Coloplast Group, and C.R. BARD. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 22 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• CD19 Therapeutics Market Inclined to Deliver Positive Growth Results until 2025 - The human immune system is composed of various types of specialized molecules and cells, which are involved in complicated interactions and activities to assist immune response. Immunotherapies use body’s innate potential to precisely target a specific molecular antigen and produce an efficient immune response against cells that show disease symptoms. CD 19 acts on follicular dendritic cells and B-lineage cells. It plays an important role in autoimmune diseases and B cell malignancies. Hence, it is a potential target for a number of monoclonal antibodies (mAbs). For years, chemotherapy has been popularly acknowledged as one of the principle anti-tumor therapies to get rid of proliferative tumor cells. Anti-CD19 mAbs are being developed to treat CD19 autoimmune diseases and lymphomas. It is one of the most novel research areas in the field of drug discovery in the pharma industry. Several of the anti-CD19 techniques are presently being tested in clinical trials. Read Report Overview: https://www.transparencymarketresearch.com/cd19-therapeutics-market.html The global CD19 therapeutics market is driven by several important factors. Acute leukemia is regarded one of the most common forms observed in childhood malignancies, which accounts for roughly around 20% to 30% of all the pediatric malignancies depending on the age. According to CDC report, 2500 new patients are diagnosed with B-lineage acute lymphoblastic leukemia (B-ALL) in the U.S. each year. High incidence rates of non-Hodgkin’s lymphoma (NHL) have been confirmed in countries in the West. Additionally, the findings suggest that most of NHL subtypes are more predominant among men than women. CD19 is a 95-kDa transmembrane glycoprotein which belongs to the immunoglobulin (Ig) superfamily. Researchers suggest that CD 19 can act as a major positive response in regulating the B cells. Other factors driving the global CD 19 therapeutics market are rise in investment in health care by government and private organizations, increase in demand for minimal invasive surgeries, growing awareness about health, and early diagnosis of diseases. However, rise in cost of treatment, side effects associated with treatment, and lack of reimbursement policies in developing countries such as India, Singapore, and Brazil are likely to restrain the market. The pipeline of the drug comprises products across four major classes. These are antibody drug conjugates, chimeric antigen receptor (CAR) T-Cell therapy (CAR-T therapies), engineered antibodies, and bispecific antibody (BsAb). Recent approval of BLINCYTO which is a CD19 targeting bsAb and advancements in the chimeric antigen receptor (CAR) T-Cell therapies has delivered a substantial boost to the global CD 19 therapeutics market. These innovative techniques focus primarily on hematological cancers, precisely B cell malignancies. Research suggests that several key players have entered into collaborations with other stakeholders to fund the commercial and clinical development of CAR-T therapies. For instance, KTE-C19, CTL019, JCAR015, and JCAR017 are examples of late stage products discovered through collaborative approach of top pharmaceutical companies. Other than pharma companies, the top research institutes involved in this area include the University of Pennsylvania, the MD Anderson Cancer Centre, the Memorial Sloan Kettering Cancer Center (MSKCC), the National Cancer Institute (NCI), and the Fred Hutchinson Cancer Research Center (FHCRC). Treatment of hematological malignancies is the primary focus of drug developers. However, approaches are also on track to use these therapies in the treatment of other symptoms including autoimmune diseases and solid tumors. North America is the major market for CD19 therapeutics driven by rise in health care funding, presence of top players and availability of reimbursement policies. Asia Pacific is anticipated to grow rapidly in the next few years due to rise in geriatric population, increase in per capita income, and growing health care infrastructure. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30362 The global CD19 therapeutics market is highly fragmented, with presence of large number start-ups and some of the top research organizations. Top players in this market are Bellicum Pharmaceuticals, Amgen, ImmunoGen, Affimed, MedImmune, Merck, and Novartis Juno Therapeutics. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 22 2019 Hits: 2 Rating: 0.00 Votes: 0) Rate It

• Vascular Graft Market - Rise in Demand of Vascular Grafts to Drive the Demand - Vascular graft has been a prosthetic of choice among the vascular and other cardiovascular surgeons worldwide due to its strong, inert and biocompatible design which also varies in sizes and configurations in order to improve vascular access. The rise in vascular graft usage has been increased due to increase in cardiovascular diseases and diabetes. Increase in geriatric population, demand of new technological advancements in vascular access, rise in demand of vascular grafts among vascular patients can also accelerate the growth in vascular graft market. Risk of infection due to diabetes mellitus and immune response can increase some serious complications such as sepsis, amputation, disruption of infected anastomotic rigid line with a rupture, etc. can restrain the market growth. Read Report Overview: https://www.transparencymarketresearch.com/vascular-graft-market.html The global vascular graft market is forecast to reach US$3.29 bn by the end of 2024, from US$2.15 bn in 2015. If these figures hold true, the global vascular grafts market will exhibit a CAGR of 5.0% between 2016 and 2024. Based on product, the vascular graft market is segmented as endovascular stent graft, peripheral vascular graft, hemodialysis access graft, bypass graft and others. The endovascular stent graft segment dominated the global vascular graft market accounting for the share of 41.0% in 2015 as these devices are mostly utilized by the vascular surgeons for abnormal aortic disorders or aneurysm caused due to cardiovascular disorders or diabetes, and smoking. The hemodialysis segment is also expected to register the fastest growth during the forecast period due to increase in number of diabetes patients. Bypass graft segment is projected to grow with a second highest CAGR between 2016 and 2024 due to increase in number of incidences of coronary artery diseases caused due to increase in obesity and unhealthy food habits. Vascular grafts are used by various end users including hospitals, ambulatory surgical centers, specialty clinics, cardiac catheterization laboratories, and others. The hospital end user segment held the largest market share in 2015 owing to increasing incidence of cardiovascular disease, introduction of technological modification on grafts by different key players in the form of usage of different sources. The segment is also projected to grow at the fastest CAGR within the end user segment. The major factor driving the hospital end user segment is that most of the vascular graft with latest technological source & design availability in hospitals. Furthermore, continuous rise in the incidence of diabetes, cardiovascular disease are also expected to boost the growth of hospital segment during the forecast period from 2016 to 2024. Based on the source segment, synthetic vascular graft is expected to have higher market share by 2024 in compare to biological and biosynthetic vascular grafts. Vascular grafts are also used for various application including coronary artery disease; aneurysm; vascular occlusion; renal failure, and others. The coronary artery disease segment is likely to grow with higher CAGR between 2016 and 2024. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11096 The global vascular graft market has been segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa., which are further categorized into various countries under each region. North America dominated the global vascular graft market in 2015 with a share of 45.0% due to factors such as increasing prevalence of cardiovascular diseases and better healthcare awareness program for diabetes. Furthermore, technological developments and increasing expenditure by major key players for development of vascular graft are also boosting the growth of the vascular graft market in North America. According to the Journal of BioMed Research International, (2013), cardiovascular diseases (CVD) cause 3% of all deaths in North America. Also, the American Heart Association (AHA) policy statement concluded that cardiovascular disease treatment cost will rise to US$ 1 trillion annually in the U.S. by 2030 which can increase the demand in various cardiovascular devices which is likely to drive the growth of the vascular graft market. However, Asia Pacific is projected to highest growth rate over the forecast period. The rationale behind such high growth has been attributed due to increase in geriatric population, set up of distribution channels by key players. Moreover, improving healthcare infrastructure and medical tourism would also drive the growth of the vascular graft market in the next few years. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11096 W.L. Gore & Associates, Inc. dominated the global vascular graft market in 2015. Major factors attributed to its dominance are product portfolio and widespread market presence. Other players in the global vascular graft market include Vascular Grafts Solutions Ltd., Heart Medical Europe BV, C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG (Getinge Group), Cook Medical, Inc., B. Braun Melsungen AG, Medtronic plc, LeMaitre Vascular, Inc., ARTEGRAFT, Vascutek Ltd. (Terumo Company) and others. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Tue Jan 22 2019 Hits: 3 Rating: 0.00 Votes: 0) Rate It

• Healthcare Automation Market: Increasing Technological Advancement to Boost Market Growth - Apheresis procedures have been performed since 1950’s for various blood purification and blood component separation purpose. Apheresis is a procedure of blood component separation using centrifugation or membrane filtration technology. This procedure is performed either for donation of a blood component or for treatment of a disease by removal of the diseased or disease causing blood component. Whole blood is extracted from donor or patient’s body, processed through apheresis machine, and the desired blood components are separated based on their molecular weight, size, and affinity for particular substance. The remaining blood is transfused back to donor or patient’s body. Apheresis procedures are performed across the globe for treatment of various neurological, renal, hematological, autoimmune and other disease. Read Report Overview: https://www.transparencymarketresearch.com/apheresis-market.html In the past few years, apheresis procedures have witnessed a stark rise in the number and areas of applications and the global market for these procedures continues to rise at an excellent pace. Presently, a variety of apheresis procedures are widely used as a part of treatment in various renal, neurology, hematology, cardiovascular and autoimmune diseases. Transparency Market Research states that the global apheresis market was valued at US$1.85 Bn. The market is projected to expand at a CAGR of 10.2% from 2017 to 2025 and reach US$ 4.33 Bn by 2025. In terms of procedure, the global apheresis market is segmented in the report into plasmapheresis, photopheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis and others. Of these, the segment of plasmapheresis dominated the global apheresis market in terms of revenue contribution in 2016, chiefly owing to high number of donor plasmapheresis procedures undertaken every year global and the vast of applications of therapeutic plasma exchange. The segment is also projected account for a notable share in the global market over the report’s forecast period and expand at a CAGR of 8.9% from 2017 to 2025. However, the segment of photopheresis is expected to lead in terms of rate of growth as the segment is projected to exhibit an excellent 12.2% CAGR from 2017 and 2025. The vast technological advancements observed in the field of photophersis in the past few years have led to a vast rise in the procedure’s vast applications in areas such as cancer and hematology disease treatment. Perceive the Sample of the Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=896 From a geographical standpoint, the global apheresis market has been segmented in the report into five regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominated the global apheresis market in 2016 owing to its well-established healthcare infrastructure and high demand for plasma for production of plasma derived medicines. Disposables products segment is anticipated to contribute largest share in North America apheresis market. Asia Pacific, with its considerably established apheresis market in countries such as Japan and emerging economies such as India and China, is projected to witness exponential growth during the forecast period. The regional market is expected to exhibit an excellent CAGR of 11.2% from 2017 to 2025. Factors such as the vast rise in the prevalence of chronic diseases, high geriatric population, and increasing healthcare expenditure in this region will play the key role in upping the demand for apheresis procedures in the next few years. Some of the leading players operating in the global apheresis market are Asahi Kasei Medical Co. Ltd., Terumo Corporation, Haemonetics Corporation, Fresenius Kabi AG, Cerus Corporation, B. Braun Melsungen AG, Kawasumi Laboratories Inc., NIKKISO CO., LTD., Therakos, Inc., and Medica S.p.A. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=896 About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 21 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• Avascular Necrosis Market Insights Report 2018 - Research and Markets - The global avascular necrosis market size was valued at US$ 512.9 million in 2017, and is expected to witness a CAGR of 6.0% over the forecast period (2018 – 2026). Avascular necrosis (AVN) also termed as osteonecrosis, or aseptic necrosis, or ischemic bone necrosis, a condition resulting in the death of bone cells due to loss of blood supply. It often leads to collapse of the joint surface and subsequent arthritis due to an irregular joint surface. Avascular necrosis affects the ends (epiphysis) of long bones such as femur, upper humerus, and bones of ankle joint. Usually it develops due to combination of various factors including metabolic, genetic, increased alcohol consumption, smoking, and other diseases. An X-ray is generally used to diagnose cause of joint pain. However, magnetic resonance imaging (MRI), is the most sensitive method for diagnosing avascular necrosis in early stages. Unlike X-rays, bone scans, and computed/computerized tomography (CT) scans, MRI detects chemical changes in bone marrow and shows avascular necrosis in its earliest stages. Nonsurgical treatment options for avascular necrosis such as anti-inflammatory medications, activity changes, and crutches can help relieve pain and slow progression of the disease. Surgical treatment include core decompression, bone and cartilage grafting, and total hip replacement. Based on the cause, avascular necrosis can be classified as traumatic and non-traumatic avascular necrosis. According to the Science Direct Journal 2010 report, traumatic injury such as ankle sprain, fracture and joint dislocation is the most common cause of AVN, which can occur eight hours after disruption to the blood supply. Non-traumatic avascular necrosis occurs usually at young age and its causes include chronic liver disease, corticosteroids, decompression sickness, fat embolism syndrome, Gaucher disease, gout, hyperlipidaemia, haemoglobinopathy, metabolic bone disease, systemic chemotherapy systemic lupus erythematosus, and alcoholism among others. Excessive alcohol consumption and long-term, high dose systemic corticosteroid use are the major risk factors for avascular necrosis. According to World Journal of Orthopedics, 2015, avascular necrosis usually affects people between 30 and 50 years of age. Also, from the same source, about 10,000 to 20,000 people develop osteonecrosis each year in the U.S. According to National Organization for Rare Disorders’ 2015 data, alcohol consumption and corticosteroid use affects about 30% and 35% of all people with non-traumatic avascular necrosis, respectively across the globe. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2218 Other risk factors or conditions associated with non-traumatic osteonecrosis include autoimmune disease, cancer, decompression disease (Caisson disease), Gaucher disease, pancreatitis, HIV infection, and blood disorders such as sickle cell disease. Certain medical treatments including radiation therapy and chemotherapy can also cause osteonecrosis. Moreover, people who have undergone organ transplants are at high developmental risk of osteonecrosis. Technological advancement in therapies for avascular necrosis such as Advanced Therapy Medicinal Products (ATMPs) is expected to boost avascular necrosis market. Advanced Therapy Medicinal Products is a class of innovative therapies that comprises of gene therapy, somatic cell therapy, and tissue-engineered products. Avascular Necrosis Market Restraints High cost of surgical treatments and delay in diagnosis due to asymptomatic nature of this condition at early stage are the major restraining factors for avascular necrosis market growth. For instance, according to Blue Cross Blue Shield of North Carolina, a total hip replacement procedure usually cost between US$ 31,839 and US$ 44,816, with an average cost of US$ 39,299. Avascular Necrosis Market - Regional Insights On the basis of region, the global avascular necrosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to generate a significant revenue share in global avascular necrosis market during the forecast period due to increasing prevalence of avascular necrosis and prior Food and Drug Administration (FDA) approval for the new avascular necrosis treatments in the region. For instance, according to National Center for Biotechnology Information (NCBI), 2015, about 20,000 to 30,000 new patients are diagnosed with avascular necrosis every year in the U.S. Asia Pacific avascular necrosis market is expected to foresee highest growth rate during the forecast period, owing to increase in development activities for the treatment of avascular necrosis by various key players in this region. For instance, in 2017, Asahi Kasei Corporation and Bone Therapeutics signed a license agreement for the development and commercialization of PREOB in Japan. PREOB is an autologous osteoblastic cell therapy product derived from ex vivo cultured bone marrow cells of the patients. Click To Reading More On Avascular Necrosis Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Jan 21 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Veterinary Nutraceuticals Market Estimation, Dynamics, Regional Share, Trends - Pet food supplements or nutraceuticals are defined as either therapeutic or dietary supplement. Dietary nutrients or supplements are substances added to petfoods in order to make them nutritionally completely balanced. Changing aspects of veterinary nutraceuticals market The global veterinary nutraceuticals market is accelerated to grow on a substantial rate due to factors such as- • Use and demand of pet supplements and nutraceuticals • Rise in adoption of companion animals • Increased in expenditure on pet health to choose nutraceuticals over pharmaceuticals • Rising health benefits and safety concerns with nutraceuticals However, strict regulations policies in Europe and limited awareness in low-income countries impede the market growth of veterinary nutraceuticals market. Regional analysis: North America holds the largest market share especially in U.S. due to increased numbers of pet. While Canadian veterinary nutraceuticals market is growing due to increased number of companion animals in household leading to demand of pet food supply. Countries such as Germany and China veterinary nutraceuticals market is also growing at a faster rate due to increased awareness for veterinary nutraceuticals supplements, rising adoption of companion animals coupled with demand for good quality of pet food. Read more Insights at https://www.precisionbusinessinsights.com/market-reports/veterinary-nutraceuticals-market/ Some of the key market players in the global Veterinary Nutraceuticals Market: • DSM • Diana group • BASF • Merial • Nutraceutical International LLC. The global veterinary nutraceuticals market is divided into following categories- By product type • Vitamins • Minerals • Enzymes • Probiotics • Omega-3-fatty acids • Others By animal type • Dogs • Cats • Birds • Fish • Others Avail free sample report at https://bit.ly/2DLqeSs By application • Immune system • Weight management • Digestive health management • Pain management • Others By geographical regions • North America • Latin America • Asia-Pacific • Europe • The Middle East & Africa About Precision Business Insights Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs. (Added: Mon Jan 21 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Varicose Vein Treatment Market -

  Unattended varicose veins can cause one severe pain through swelling, ulceration, venous eczema, and lipodermatosclerosis. Treating them through appropriate measures becomes quite crucial. One may opt for non-surgical remedies such as sclerotherapy, leg elevation, or alternative invasive techniques such as endovenous laser treatments. Collectively, these therapies can be addressed as varicose vein treatments, medically-practiced in all parts of the world. The demand for such varicose vein treatments is expected to grow in the years to come.

  Future Market Insights recently conducted its forecast study on the global market for varicose vein treatments, estimating the market’s current value at just over US$ 500 Mn. The report, titled “Varicose Vein Treatment Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” projects that rising prevalence of obesity will fuel the incidence rate of varicose veins in the world. Occurrence of varicose vein is medically-proven to be higher among obese people. Along with this, the demand for varicose vein treatments is also expected to grow on the account of effectiveness of the treatments, utilisation of user-friendly devices, and growing emphasis of medical practitioners on ensuring patient safety during critical treatment of varicose veins. Towards the end of 2026, the global market for varicose vein treatment will have reached value of US$ 931.4 Mn, registering a robust growth at 6.4% CAGR.

  Varicose Vein Treatments: Market Opportunities

  Backed with strong clinical evidence, endovenous laser ablation devices are more popular to treat varicose veins. However, compared to other procedures such as foam fillers, vein stripping costs, and blast with electricity, endscopic variceal ligation (EVL) is a costlier treatment alternative. Launch of cost-effective EVL devices will work as a favourable opportunity for new entrants as well as existing players in the market. Decreasing the procedure costs and enhancing the adoption of affordable devices will cumulatively boost the adoption of varicose vein treatments.

  Request Sample Report @  https://www.futuremarketinsights.com/reports/sample/rep-gb-2538

   Among the wide variety of endovenous laser ablation devices available in the market, some of them may lead to complications such as thrombophlebitis, nerve damage, burns and deep vein thrombosis conditions. There is a potential opportunity for endovenous laser ablation device manufacturers to tap the larger market by offering competitive products that cause lesser complications.

  APEJ Varicose Vein Treatment Market to Record Speedy Growth

  Apropos the report, more than 40% of the market revenues will remain concentrated in North America, throughout the forecast period. By 2026-end, North America’s varicose vein treatment market will have reached a value of US$ 420 Mn. US-based AngioDynamics, Inc. will be observed as a key player in the market during this period. In terms of revenue growth, the varicose vein treatment market in Asia-Pacific excluding Japan (APEJ) region is projected to be at the forefront. By exhibiting 7% CAGR, the APEJ varicose vein treatment market will witness active participation of Korean medical device manufacturer, Wontech Co., Ltd. Apart from these, Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, Energist Ltd. and intros Medical Laser GmbH are other companies partaking in the growth of global varicose vein treatment market.

  Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-2538

  The report further reveals that hospitals and ambulatory surgical centres as end-users will account for larger share of global revenues, while specialised clinics will register fastest revenue growth at 7.2% CAGR. The report also identifies endovenous laser treatment as the dominant varicose vein treatment in the market, procuring revenues worth over US$ 500 Mn by end of 2026.

  (Added: Mon Jan 21 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Liquid Biopsy Market is Expected to Foresee an Outstanding CAGR of 20.6% by 2027 - The global demand for liquid biopsy test is increasing as a result of rapid adoption of new technologies and increasing adverse patient-related cases. In its report titled Liquid Biopsy Market - Global Industry Analysis and Opportunity Assessment, 2016–2026, FMI has presented an in-depth analysis of the liquid biopsy market for forecast period 2016–2026. Developed economies are witnessing rapid adoption of liquid biopsy test as it provides proper decision support regarding anti-cancerous drugs to doctors, physicians and oncologists. As well expected, North America is expected to dominate the overall liquid biopsy market in terms of revenue generation throughout the forecast period. A false positive occurs when the sample indicates cancer, even if no danger is actually present – either because the tumor has already been caught or eradicated by the immune system or because it continues to grow so slowly that it will not harm the patient in his or her lifetime. False positive results can lead to overtreatment, which may do more damage than good in the long run. Do Inquiry to Get the Sample of Report Here @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5593  In-Depth Analysis of the Global Liquid Biopsy Market Key segments in the liquid biopsy market are circulating tumour cells, circulating tumour nucleic acid and exosomes, in which the circulating tumour cells biomarkers is expected to hold major share in the liquid biopsy market over the forecast period, as CTCs have enhanced clinical applications which include prediction of cancer prognosis; selection and monitoring of therapeutic treatment; and drug targeted therapy. In the liquid biopsy market, North America is expected to be the most lucrative regional market in terms of revenue generation, followed by Western Europe. Ageing population in Japan and rising incidence of cancers are factors expected to fuel the adoption of liquid biopsy procedure and drive the growth of the liquid biopsy market in Japan. The liquid biopsy market in APEJ is expected to witness significant growth due to increasing awareness and increasing prevalence of cancer in the region. However, limited access to financial resources and lack of effective R&D are factors expected to dent the revenue growth of the liquid biopsy market in the region. Currently, liquid biopsy is gaining huge acceptance by diagnostic laboratories and research institutes for diagnosis of various chronic diseases including cancer. Critical information about cancer can be detected through liquid biopsy procedures, involving a biofluid sample – blood or urine.  These liquid biopsy tests can eliminate numerous problems associated with tissue biopsies. Also, liquid biopsy provides a detailed view of a tumor’s genetic makeup including complete molecular information of a tumor. Thus providing huge scope for the companies to launch innovative tests in the liquid biopsy market. Strategies Adopted by Companies in the Global Liquid Biopsy Market The companies in the liquid biopsy market are introducing innovative molecular diagnostic tests as means for boosting incremental innovation. These innovative molecular diagnostic tests are minimally invasive. Also, liquid biopsy tests provide less-expensive way to monitor patients throughout treatment. For example, in June 2016, Trovagene developed Trovera – a urine-based liquid biopsy test to detect and monitor cancer. This eliminates the need to have repeat surgical biopsies. Genomic Health, Inc. launched a liquid biopsy test called Oncotype SEQ Liquid Select to detect genomic alterationsm with late-stage lung, breast, colon, melanoma, ovarian or gastrointestinal cancer. Methodology With Latest Advancements and Application @ https://www.futuremarketinsights.com/askus/rep-gb-5593  Liquid biopsy companies are partnering with pharmaceutical companies. Major liquid biopsy diagnostic companies are entering into strategic alliances with pharmaceutical companies with the objective to develop anti-cancer drugs and liquid biopsy tests in order to attain leadership position in the liquid biopsy market. Biocept, Inc. a liquid biopsy company entered into a services agreement with a biopharmaceutical company to develop targeted liquid biopsy tests for multiple tumor types and molecular targets. Companies Biocartis and Merck KGaA signed a collaborative pact to develop and commercialize a new liquid biopsy RAS biomarker test in 2016 – to aid patients with metastatic colorectal cancer. About Us Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers. Contact Us U.S. Office 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 Email: sales@futuremarketinsights.com Web: https://www.futuremarketinsights.com/ (Added: Mon Jan 21 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• Optometry Market - Increasing Elderly Population with Vision Problems Propels Demand - At present, the global optometry market is fragmented in nature on account of the presence of numerous players. To retain and grow their market shares in such a fragmented landscape, most players are seen competing with one another on the basis of better therapies and treatments. Some of the dominant players in the market have established a solid stronghold with their extensive geographical outreach and a diverse product portfolio. Read Report Overview: https://www.transparencymarketresearch.com/optometry-market.html Serving to stoke growth in the global optometry market is the ever-increasing elderly population who are highly susceptible to visual problems and rising instances of eye ailments on account of chronic health conditions such as diabetes. As a result, eye diseases, namely diabetic retinopathy, age-related macular degeneration, cataracts, and glaucoma are increasing by the day. Besides, the surging popularity of eye wear fashion and rising disposable incomes of people have also proved beneficial to the global optometry market. A report by Transparency Market Research projects the global optometry market to rise at a lackluster CAGR of 4.1% from 2017 to 2025 to become worth US$79.871 bn by 2025 from US$55.974 bn in 2016. Depending upon the type of products, the global optometry market can be broadly split into vision care equipment and therapeutics. The therapeutics segment again can be further divided into anti-inflammatory drugs, anti-fungal drugs, anti-infective drugs, anti-infective drugs, anti-infective drugs, and anti-allergy drugs. Of them, the anti-inflammatory drugs contributed the most to revenue – almost 32.5% in 2016. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11810 The segment of vision care equipment in the optometry market can also be divided further into eye glasses and contact lenses. The eye glasses segment, among them, is projected to rake in higher revenue in the years to come. However, contact lenses too are expected to clock healthy growth in the near future on account of the rising awareness about the various types of contact lenses available in the market and their use in treating refractive errors. From a geographical standpoint, North America held maximum share of 36.5% in the global optometry market in 2016. Europe trailed North America vis-à-vis market share in 2016. The dominant positions of the two regions is attributed to their developed economies and advanced healthcare infrastructures. Further, the high degree of awareness among the people in the region pertaining to the various treatments available for eye diseases is also serving to drive their markets. Currently, the vision care segment of the optometry market contributes the most to the revenue in the two regions. The optometry market in North America is primarily being driven by the U.S., whereas the market in Europe is being powered mainly by Germany. In terms of growth rate, on the other hand, Asia Pacific is slated to outshine all other regions by clocking a CAGR of 5.1% from 2017 to 2025. The market in the region is being propelled by its burgeoning population, mushrooming healthcare facilities, and rising knowledge about eye ailments. The markets in Latin America and the Middle East and Africa too are expected to witness impressive growth in the next couple of years on the back of increasing initiatives by the governments in the region to overhaul the healthcare industry. Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11810 Some of the prominent participants in the global optometry market are CooperVision, Johnson & Johnson Vision Care, Inc., Novartis AG, Pfizer, Inc., Valeant Pharmaceuticals International, Inc., Allergan, and Essilor. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 21 2019 Hits: 0 Rating: 0.00 Votes: 0) Rate It

• RetailPharma Celebrates Republic Day with Exclusive Deals - Republic Day is a national holiday in India, which is celebrated across the country. On Republic Day RetailPharma has announced the Best Sale, Deals, and Exciting Offers & Discounts. In this 70th Republic day, the online Pharmacy Store Retailpharma is ready to bring a parade of offers and discounts. So get ready to enjoy the republic day savings offers. As you all know RetailPharma is places where we can find anything you virtually want to buy from online store. Retailpharma guarantees you vast selection, low prices, fast and reliable delivery, and a trusted and convenient online shopping experience. And now in this occasion of Republic day RetailpharmaIndia has come up with another wonderful festival called Republic Day with Exclusive Deals which will be a Pre-festive offer. This Exclusive Deals will be conducted for limited period that is from Jan 19 to Jan 26, 2019. It’s gonna be a great festival with mind-blowing offers, exciting discounts and amazing selective HealthCare Cosmetic Products. You can enjoy RetailPharma Republic day offers in this Exclusive Deals which have included huge range of Health Care, Cosmetic, Personal Care, Household, Ayurvedic, Helath care Aid etc. You people may be aware of the fact that doing something that makes you feel good can uplift your mood and cheers you up. And in fact Shopping is one activity which makes a million people happy. So shop and Celebrates this Republic Day with RetailPharma Exclusive Deals RetailPharma presents you Republic Day Sale from where you can buy your Wide Range of Personal care, Health care, Cosmetic, Pet care, household products for upto 80% off. For your completely satisfied shopping, RetailPharma is there for you to offer Extra Discounts, Of course, you have one more offer up to 20% for every purchase you make in Mirahbelle products use code MBN20 and get 20% off on Min. Purchase Value Rs.200. Okay, then why you are waiting go and make the most out of these in this Republic day. Celebrate this Republic day by shopping online and Proud to be an Indian shopper. About Retail Pharma India Retailpharma is India's #1 online Pharmacy Marketplace to order Prescription/Otc, Cosmetic, Surgical, Personal Care products to get simply delivery at your doorstep. Website: https://www.retailpharmaindia.com/ Facebook Profile: https://www.facebook.com/RetailPharmaOfficial/ Twitter Profile: https://twitter.com/retailpharma1 Linkedin Profile: https://www.linkedin.com/company/retail-pharma-india/ Google + Profile: https://plus.google.com/u/0/+RetailPharmaOfficial Instagram Profile: retailpharmaofficial Pinterest Profile: https://in.pinterest.com/RetailPharmaOfficial/ Blog: http://pharmaretailindia.blogspot.com/ (Added: Mon Jan 21 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• RetailPharma Celebrates Republic Day with Exclusive Deals - Republic Day is a national holiday in India, which is celebrated across the country. On Republic Day RetailPharma has announced the Best Sale, Deals, and Exciting Offers & Discounts. In this 70th Republic day, the online Pharmacy Store Retailpharma is ready to bring a parade of offers and discounts. So get ready to enjoy the republic day savings offers. As you all know RetailPharma is places where we can find anything you virtually want to buy from online store. Retailpharma guarantees you vast selection, low prices, fast and reliable delivery, and a trusted and convenient online shopping experience. And now in this occasion of Republic day RetailpharmaIndia has come up with another wonderful festival called Republic Day with Exclusive Deals which will be a Pre-festive offer. This Exclusive Deals will be conducted for limited period that is from Jan 19 to Jan 26, 2019. It’s gonna be a great festival with mind-blowing offers, exciting discounts and amazing selective HealthCare Cosmetic Products. You can enjoy RetailPharma Republic day offers in this Exclusive Deals which have included huge range of Health Care, Cosmetic, Personal Care, Household, Ayurvedic, Helath care Aid etc. You people may be aware of the fact that doing something that makes you feel good can uplift your mood and cheers you up. And in fact Shopping is one activity which makes a million people happy. So shop and Celebrates this Republic Day with RetailPharma Exclusive Deals RetailPharma presents you Republic Day Sale from where you can buy your Wide Range of Personal care, Health care, Cosmetic, Pet care, household products for upto 80% off. For your completely satisfied shopping, RetailPharma is there for you to offer Extra Discounts, Of course, you have one more offer up to 20% for every purchase you make in Mirahbelle products use code MBN20 and get 20% off on Min. Purchase Value Rs.200. Okay, then why you are waiting go and make the most out of these in this Republic day. Celebrate this Republic day by shopping online and Proud to be an Indian shopper. About Retail Pharma India Retailpharma is India's #1 online Pharmacy Marketplace to order Prescription/Otc, Cosmetic, Surgical, Personal Care products to get simply delivery at your doorstep. Website: https://www.retailpharmaindia.com/ Facebook Profile: https://www.facebook.com/RetailPharmaOfficial/ Twitter Profile: https://twitter.com/retailpharma1 Linkedin Profile: https://www.linkedin.com/company/retail-pharma-india/ Google + Profile: https://plus.google.com/u/0/+RetailPharmaOfficial Instagram Profile: retailpharmaofficial Pinterest Profile: https://in.pinterest.com/RetailPharmaOfficial/ Blog: http://pharmaretailindia.blogspot.com/ (Added: Mon Jan 21 2019 Hits: 28 Rating: 0.00 Votes: 0) Rate It

• Endoscopy Video Processor Market to Reflect Steady Growth During 2018 – 2026 - Endoscopy Video Processor Market Drivers Rapid innovation in endoscopy technologies is expected to drive growth of the endoscopy video processor market. For instance, MATRIX Spectar, a product of XION GmbH, is the first adaptive camera processor, which allows operation of all camera heads, rigid and flexible video endoscopes, as well as video compact systems for 2D and 3D endoscopy with the best image quality. For this innovation, XION GmbH won Innovation Award Berlin Brandenburg in 2016. It has optical and electronic zoom system designed for native sensor resolutions up to 4K. Moreover, in March 2017, Olympus Corporation launched VISERA ELITE II, a compact surgical endoscope system with an infra-red (IR) imaging capability. This makes the system smaller and lighter and provides wide space to hospital and aids in reducing providers workload. Furthermore, in December 2017, company launched another product, LTF-S300-10-3D ENDOEYE FLEX 3D deflectable videoscope, a new 3D surgical endoscope, designed for use with VISERA ELITE II. Endoscopy Video Processor Market Restraint Product recalls due to failures in meeting regulatory standards as per U.S. Food and Drug Administration (USFDA) is expected to restrain growth of the endoscopy video processor market. For instance, in October 2017, USFDA recalled Fujifilm Medical Systems U.S.A., Inc.'s product- Ultrasonic Endoscope Model Number ED-530XT (a duodenoscope, designed for visualizing the duodenum and the upper digestive track) for updating labels and design and correcting past incidence of infections. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2242 Endoscopy Video Processor Market - Regional Analysis On the basis of region, the global endoscopy video processor market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Based on region, North America is projected to gain major share in the endoscopy video processor market, owing to rapid development of imaging technologies for endoscopic procedures. For instance, Olympus Medical Systems Group, in October 2018, introduced OER-Mini tabletop endoscope reprocessor for ear, nose, and throat in the U.S. OER-Mini is a tabletop endoscope reprocessor that helps to improve reprocessing efficiency by removing some manual steps of reprocessing endoscopes with high level disinfecting. Asia Pacific region is forecasted to witness significant growth in the endoscopy video processor market due to expansion of key players in India. For instance, in October 2018, Fujifilm India Private Limited, launched ELUXEO 7000 Series— novel image-enhanced endoscopy products— which have Blue Light Imaging (BLI) / Linked Color Imaging (LCI) technology to help in early detection of all types of gastro cancers, in India. Endoscopy Video Processor Market - Competitive Analysis Key players in endoscopy video processor market include Fujifilm India, Olympus Corporation, Karl Storz SE & Co. KG, Stryker, XION GmbH, Boston Scientific Corporation, Richard Wolf GmbH, Shenda endoscope china shenda endoscope., SonoScape Medical Corp., and Media Data Systems Pte Ltd. Click To Reading More On Endoscopy Video Processor Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:sales@coherentmarketinsights.com Visit our news Website: https://www.coherentwire.com (Added: Mon Jan 21 2019 Hits: 11 Rating: 0.00 Votes: 0) Rate It

• CT Scanners Market - Improve Healthcare Infrastructure to Boost the Market Growth - The healthcare industry has always been prosperous and substantially dependent on product innovation. CT scanners market is no different, which has tremendous potential across the globe, especially for those vendors who can stay in-sync with the latest technologies. The demand in the global CT scanners market is projected to increment at a CAGR of 5.9% during the forecast period of 2017 to 2022, gaining traction from a number of factors such as increasing preference of the patients for minimally invasive diagnostic procedures, improve healthcare infrastructure in various emerging economies, recent product improvements including the advent of portable CT scanners, and escalating geriatric population who require bedside imaging and home healthcare. In terms of revenue, the global CT scanners market is estimated to be worth US$6,429.8 mn by 2022, considerably up from its evaluated worth of US$4,834.1 mn by 2017. Read Report Overview: https://www.transparencymarketresearch.com/ct-scanners.html Based on product type, the global CT scanners market has been segmented into C-Arm and O-Arm. The latter accounted for 70.2% of the overall demand in CT scanners market in 2017, and is anticipated to maintain similar chunk of demand until 2022 too, wherein it will promise a revenue of US$4,530.6 mn. The demand for O-Arm CT scanners segment is projected for a CAGR of 6.0% during the forecast period of 2017 to 2022. Based on end user, the market for CT scanners has been bifurcated into hospitals, diagnostic centers, research and academic institution, ambulatory care centers, veterinary clinics and hospitals, and other end users. On the basis of modality, the CT scanners market is categorized into standalone and portable, whereas technology-wise, the market has been classified into high-slice, mid-slice, low-slice, and cone beam. The portable CT scanners segment is gaining popularity at a rapid rate, which is a reflection of increasing number of device installations across developed markets, lower switching costs provided by these portable products, and growing application horizons. Geographically, the report takes stock of the potential of CT scanners market in the regions of North America, Latin America, Europe, Asia Pacific except Japan (APEJ), and the Middle East and Africa (MEA), as well as in the country of Japan. In 2017, North America CT scanners market was most profitable among all regions, generating a revenue of US$1,844.7 mn, and expanding at an above-average CAGR of 6.2% during the forecast period of 2017 to 2022, it is estimated to be worth US$2,486.4 mn by 2022. Escalating geriatric population, increasing emphasis on minimally invasive procedures, robust reimbursement policies, and rising private and public investments are some of the key factors augmenting the demand in the North America CT scanners market. Europe is currently the second most profitable region, promising a demand for CT scanners worth of US$1,860.2 mn by 2022. This is a reflection of early adoption of new technology and moderate healthcare facilities in the region. That being said, APEJ region is projected to the best growth rate, which equal to North America. This region includes two of the most promising country-wide markets of India and China, who are among the fastest growing economies in the World. Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=852 GE Healthcare, Koninklijke Philips N.V., Medtronic PLC, Siemens AG, Accuray Incorporated, Carestream Health, Inc., Hitachi Ltd, Koning Corporation, Neusoft Corporation, Planmed Oy, Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co., Ltd., Toshiba Corporation, and Shimadzu Corporation are some of the key companies currently operating in the global CT scanners market. Most of these companies are concentrating on developing portable products and increasing their geographical presence to strengthen their position in the market. About Us Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact Transparency Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: amanpreet@tmr.com Website: https://www.transparencymarketresearch.com/ (Added: Mon Jan 21 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

• 2nd International Conference on Plastic & Cosmetic Surgery - Conferenceseries LLC Ltd is organizing Plastic Surgery in 2019 at Chicago, USA. The Conference is mainly focuses on the latest and exciting innovations in every area of Plastic Surgery, Cosmetology, Re-constructive surgery. We are glad to announce the inception of the 2nd International Conference on Plastic & Cosmetic Surgery, going to be held at Chicago, USA, during August 02-03, 2019. Conference Series LLC Ltd is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Science Congresses in all the major scientific disciplines, including Clinical, Medical, Pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, The Middle East, and Asia Pacific. It is reaching over 25 million researchers, scholars, students, professionals and corporate entities all over the globe. (Added: Mon Jan 21 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... [>>]